Tim McCarthy, Chairman of ImmuPharma #IMM – 26th January 2017
26th January 2017 - 4:21 pmTim McCarthy, Chairman of ImmuPharma talks to Vox Markets and gives update on their, Phase III Clinical Trials for its lead drug Lupuzor™.
Tim McCarthy, Chairman of ImmuPharma talks to Vox Markets and gives update on their, Phase III Clinical Trials for its lead drug Lupuzor™.